About the Journal
Focus and Scope
INNOSC Biomaterials and Stem Cells is a multidisciplinary peer-reviewed journal related to biomaterials, stem cells, and tissue engineering. The main focus of this journal is to provide the solution for the human health related issues using stem cells and biomaterials technologies. Tissue Engineering is an interdisciplinary field of research with the combination of Materials Science, Engineering Science, Life Science, Medical Science with the aim to develop the tissues/organs which can be potentially used in repair or restore of the defective organs or lost tissues.
This journal will provide the recent technological development in biomaterial and stem cells in the form of original research articles, review articles, mini-reviews, notes, letters to editor, case reports, letters and editorials.
The scope of INNOSC Biomaterials and Stem Cells includes, but is not limited to,
- Preparation, characterization, toxicological evaluation and applications of synthetic and natural biomaterials
- Biocompatibility and biodegradability of materials
- Cells and biomaterials interactions
- Metals, implants, screws, and plates for tissue regenerations
- Isolation, characterization and differentiation of stem cells
- Organoids development
- Tissue engineering and regenerative medicine (including 3D printing, scaffolds and nanotechnological approach)
- Drug delivery
Peer Review Process
The editorial process and peer-review workflow of the journal are monitored by the Editor-in-Chief, Editorial Board Members and professional in-house editors. In the initial stage, the submitted manuscript is reviewed and evaluated by in-house editors to ensure the quality of the submitted manuscripts and whether it is matched to the focus and scope and policies of the journal. The Editor-in-Chief has then confirmed the quality of the manuscript before assigning to an Editorial Board Member or in-house editor to handle the review process. The Editorial Board Member or in-house editor appoints two independent reviewers according to the topics to review the manuscripts.
The journal follows a double-blind peer review, where the identity of both the reviewers and authors of the manuscripts remain anonymous. The action ensures a fair and unbiased assessment of the manuscript by the reviewers.
Authors must suggest two to five reviewers from the academic background who are in the field of the submitted manuscripts. The list of suggested reviewers should be either included along with cover letter and manuscript as one document or submitted in the Comments to the Editor section during the manuscript submission stage. Authors are required to submit a word document stating the following information:
- Full name (first name followed by the last name)
- Institution/affiliation’s postal address
- Active email address
- Telephone number (if any)
- Fax number (if any)
However, whether or not the suggested reviewers should be recruited to review the manuscript is at the editorial office’s discretion. Please note that the editorial office has the authority to select new reviewers.
After the evaluations by reviewers have been received, the Editor-in-Chief makes a final decision and suggest one of the following recommendations to authors based on the reviewers’ report:
- Accept with minor revision
- Accept with major revision
Authors are given 20 days to resubmit the revised manuscript if the editorial decision is a minor revision. If the editorial decision is a major revision, authors need to resubmit the revised manuscript within 45 days. The resubmitted manuscript is reviewed by the Editor-in-Chief to determine whether the manuscript is acceptable. The second review by the reviewers may be needed, subject to the decision of the Editor-in-Chief, particularly, for a manuscript with major revision.
Authors may appeal for a rejected submission. Appeal requests must be made in writing to Editor-in-Chief or editorial office at email@example.com with detailed reasons for the appeal and point-by-point responses to the reviewers’ remarks in the rebuttal letter. Decisions on appeals are final without exception.
Reviewing Process Flow Chart
INNOSC Biomaterials and Stem Cells publishes four issues per year (on quarterly basis).
Open Access Policy
This journal provides immediate open access to its content on the principle that making research freely available to the public to support greater global exchange of knowledge.
Bio-Byword Scientific Publishing follows a double-blind peer review procedure for submissions of all manuscripts to its journals.
All submitted manuscripts are subject to a fair, unbiased and extensive peer review in consultation with the assigned journal’s Editorial Board Member and independent internal or external referees (usually two reviewers), who have expertise in the field of the submitted manuscripts. The peer review applies a short and rapid, but fair and professional assessment on all submitted manuscripts. The journal’s Editor-in-Chief will then make a decision based on reviewers' report before conveying to the author(s).
All submissions from the Editor-in-Chief will undergo independent peer-review and assessment by the journal’s Editorial Board Member or in-house Editor. Whether or not the manuscript should be accepted is at the discretion of the Editorial Board Member or in-house Editor based on reviewers’ report.
Copyediting and Proofs
Copyediting is a process of checking for mistakes and inconsistencies in the text, just to name a few, typographical errors and format inconsistency. Although copyediting is almost the final part of the editorial process, the authors are encouraged to write the manuscript in accordance to the journal’s criteria in order to accelerate the screening and reviewing process.
In gist, manuscripts must be written consistently in either American English or British English. The authors must ensure that the language used in the manuscript is clear and straightforward, and correct punctuations are used. In addition, the manuscripts must be written according to the format and style set by the journal (see Author Guidelines). The authors who are not native speakers of English language are advised to hire professional proofreading service and make necessary amendments before submission. Shall the authors need a proofreading and editing service from Bio-Byword Scientific Publishing, please email us at firstname.lastname@example.org to get a quotation.
High-quality, bound/unbound, print/e-prints can be purchased for all published articles.
This journal follows a strict editorial policy set by Bio-Byword Scientific Publishing. A manuscript is only eligible if it was submitted by principal/corresponding author(s) or co-authors of the manuscript. The manuscript should not be submitted by someone who is not in the list of authorship on their behalf. The principal/corresponding author will be required to submit an Authors Declaration Letter along with the manuscript, on behalf of all co-authors (if any). The journal will not accept a manuscript that has been submitted for consideration or published in any other journal. The authors need to notify the journal if the data presented in the manuscript has been presented at conferences, seminars or other forums. The author is required to check the submission checklist to ensure that these criteria are fulfilled. After acceptance, the Publisher will have the right to edit the work for the original edition and for any revision. Furthermore, any illustration, structure or table that has been published elsewhere must be reported and copyright permission for reproduction must be obtained.
Appeals and Complaints
If the submitted manuscripts have been rejected during initial screening or after peer review, the authors can make an appeal by referring it to the Editor-in-Chief of the journal by emailing to email@example.com. Complaints to Bio-Byword Scientific Publisher can be forwarded to firstname.lastname@example.org.
Conflict of Interest
The author(s) should hold responsibility in declaring any conflict of interest with respect to their work. The author(s) must provide details of any relationship with the financial bodies or funding agencies that might influence the results or interpretation of their manuscript. All authors, Editorial Board Members, reviewers and editors must disclose any association that presents a conflict of interest in the manuscript. The principal/corresponding author must download and complete the International Committee of Medical Journal Editors (ICMJE) Conflict of Interest Form on behalf of all the authors regarding potential conflicts of interest and upload the form as Supplementary File during manuscript submission. For more information, please visit www.icmje.org. Conflict of Interest declarations or statements are published in each manuscript as provided by the author(s).
Bio-Byword Scientific Publishing will not accept any submission with high similarity to the published texts in the articles or that are plagiarized under any circumstances. The journal will check the text similarity and the originality of the submitted manuscripts using commercial and widely acceptable plagiarism detection software, such as Turnitin. The plagiarism software checks the content against a database of periodicals, the Internet, and a comprehensive article database. Additionally, the report states the percentage of similarity between the uploaded manuscript and the published materials that are available in the system. Any overlapped content in the manuscript is further scrutinized for suspected plagiarism based on the publisher’s Editorial Policies. The publisher allows an overall similarity of 25% for a manuscript to be considered for publication. Published manuscripts, which are found to contain plagiarized text are retracted from the journal’s website after careful investigation and approval by the Editor-in-Chief of the journal. A ‘Retraction Note’, as well as a link to the original article, is published on the electronic version of the plagiarized manuscript and an addendum with retraction notification in the journal.
Types of Plagiarism
Bio-Byword Scientific Publishing understands that it is not easy to have a clear boundary between legitimate representation and plagiarism as the scholarly manuscripts are written after thorough review of published articles. Therefore, the publisher has outlined in the following several important features to assist the identification of different kinds of plagiarized content:
- The plagiarized words, sentences, ideas or findings from others as one’s own without proper citation and acknowledgment.
- Text recycling or self-plagiarism. The authors use a previous publication in one of the articles of the author without proper citation and acknowledgment of the original source.
- Poor paraphrasing. An entire paragraph was copied without proper paraphrasing or changing the structure of original sentences despite modification of a few words, or the sentence structure was changed but not the
- Verbatim copying of text in any original source without placing quotation marks and citing or acknowledging the original author.
- Unintentional plagiarism. The authors have properly cited an article of the original author but without sufficiently paraphrasing the original text. Similarly, manuscripts with language somewhere between paraphrasing and quoting are not acceptable. Authors should either paraphrase or quote and in both cases, cite the original source.
- It is understandable that sometimes the technical terms and/or standard procedures is hard to be paraphrased, particularly in the sections of abstract, introduction, materials and methods, discussion and conclusion. Editors must review these sections along with the explanation from the authors carefully before making decision.
Copyright and License
Open Access Policy
The journal is an open access journal that adheres to Attribution-Non Commercial 4.0 International (CC BY-NC 4.0). Under this publishing license, the authors shall retain the copyright of their work but allow the Publisher a license to publish, copy, distribute, and convey the work, provided that the correct attribution of the original creator is stated. This broad license intends to facilitate free access to, as well as the unrestricted reuse of, original works of all types. This ensures that the published work is freely and openly available in perpetuity.
Ethical Approval of Studies and Informed Consent
For human or animal experimental investigations, it is a prerequisite to provide a formal review and approval, or review and waiver, by an appropriate institutional review board or ethics committee, which should be documented in the paper. For investigations undertaken on human subjects, the manner in which the informed consent was obtained from the study participants (i.e., verbal and written) should be stated clearly in the Materials and Methods section.
In the case where a confidential case material is used in the study, the authors must obtain verbal and written consent of human subjects before they participate in the study. However, a patient consent is not required for very brief case vignettes which do not contain identifying information or if the case material is masked sufficiently to prevent identification of the patient.
The authors should inform and discuss with the study participants on the purpose(s) of publication, the possible risks and benefits and the individual’s right to withhold or withdraw consent. In the case of a minor patient, consent should be obtained from the parent(s) or guardian(s). The authors should not perform any misconduct or deceive the human subjects in obtaining their consent.
Standard Protocol on Approvals, Registrations, Patients Consents & Animal Protection
Human: All clinical investigations must be conducted according to the Declaration of Helsinki principles, as revised in 2000 and 2008. Authors must comply with the guidelines of the International Committee of Medical Journal Editors (www.icmje.org) in conjunction with the patient’s consent for research or participation in a study. Patient names, initials, or hospital numbers must not be mentioned anywhere in the manuscript (including figures and tables). Editors may request the authors to provide documentation of the formal review and recommendation from the institutional review board or ethics committee which is responsible for overseeing the study, if necessary.
Animals: For all original research manuscripts involving the use of animals, the authors should indicate whether relevant international, national and/or institutional guidelines for the care and use of laboratory animals were followed accordingly. The authors must include details of animal welfare (such as species, number, gender, age, weight, housing conditions, welfare, training and the fate of the animals at the end of the experiment) and relevant details of steps taken to ameliorate suffering in all works in the Materials and Methods section of a manuscript. Similarly, any experiments involving animals from clients or private institutions, the authors are required to get informed client consent and adhere to a high standard (best practice) of veterinary care. These details should be included in the Materials and Methods section of the manuscript.
Errata and Corrections in Published Articles
It is encouraged that authors or readers can report the journal’s editorial office or the Editorial-in-Chief on any identified errors in the published articles, authors’ name or affiliations or if they have reasons for concern over the legitimacy of a publication. In such cases, the journal will publish an ERRATUM after verifying and authorized by the Editor-in-Chief and authors of that particular article and/or replace or retract the article.
Any identified errors or violation of the publishing ethics guidelines (such as multiple submission, fake claims of authorship, plagiarism, deceitful use of data or the like) in the Articles in Press, which are the accepted articles for publication or published as E-pub Ahead of Schedule but which have not been formally published with volume/issue/page information may be “Withdrawn” from the journal. A withdrawal note links to the published article in the journal will be published stating that the article has violated the Editorial Policies and Publishing Ethics that the journal strictly adheres.
Any violations of professional ethical codes, such as multiple submission, fake claims of authorship, plagiarism, deceitful use of data or the like are retracted immediately from the journal. The journal posts a retraction title “Retraction: [article title]” linked to the published article that has been agreed and signed by the authors and/or the Editor-in-Chief. The online article is headed by a screen containing the retraction note. The original article is retained unchanged with a watermark on the PDF indicating on each page that it is “retracted.”
The HTML version of the document is removed.
Bio-Byword Scientific Publishing ensures that each article published in the journal is with the highest quality by mutual contribution and cooperation genuinely given by authors, reviewers and editors. Bio-Byword is well-aware of the potential impact of published works both on future research and society, thus, any low-quality and irreproducible review publishing models will be rejected. Additionally, Bio-Byword applies the most rigorous and unbiased peer review system to ensure that the research works published in the journal are well-recognized by peers.
Bio-Byword Scientific Publishing requests all members involved in the journal publishing process to adhere to the Core Practices on publication ethics as stipulated by COPE (Committee on Publication Ethics).
The publisher strictly adheres to the guidelines and best practices, which include Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals from the International Committee of Medical Journals Editors (ICMJE) and the Principles of Transparency and Best Practice in Scholarly Publishing developed by Committee on Publication Ethics (COPE), Directory of Open Access Journals (DOAJ), Open Access Scholarly Publishers Association (OASPA) and World Association of Medical Editors (WAME).
All complaints submitted by the authors to the journal will be addressed promptly according to the procedure set out in the COPE flowchart on complaints. The complainant may direct all inquiries and correspondence to the publisher at email@example.com.
The Publisher strictly complies with the best practice guidelines on commercial considerations as stipulated by COPE’s Code of Conduct for journal editors. The advertising terms will apply to all online, print and e-mail advertisements, which are submitted to the journal and accepted for publication. By submitting an advertisement to the journal, the advertiser agrees to be bound by these terms and conditions. Advertisements submitted for publication must comply with the laws enforced by Australia and are subject to approval from the editorial office. The journal reserves the right to refuse any advertisements at its sole discretion for any reason whatsoever, including without limitation for offensive or inappropriate content. The advertiser retains copyright to the advertisement but grants the journal a worldwide, irrevocable, non-exclusive, and transferable license to reproduce the advertisement, including any trademarks therein, and including without limitation in any future archive or database in any medium, now known or later invented.
Responsibility regarding the substance distributed by Bio-Byword Scientific Publishing in any of its journals, including any conclusion communicated in that, rests solely with the author(s) of such substance. To the most extreme degree allowed by pertinent law, the publisher (all alone sake, and for the benefit of its staff and individuals from its editorial board) disavows responsibility on all damage and additional harm (regardless of whether monetary or something else) to people or property, coming about specifically or in a roundabout way from any thoughts, strategies, directions or items (counting mistakes in the same) alluded to in the substance of any of the publisher's journals.
Why INNOSC Biomaterials and Stem Cells?
INNOSC journal series are new flagship journals of Bio-Byword Scientific Publishing, with INNOSC Stem Cells and Tissue Engineering being one of the first journals launched among others. Although time is needed for this brand-new journal to achieve wide recognition and outstanding Impact Factor results, the publisher ensures a friendly manuscript submission system, fair and unbiased peer review process, rapid publication, copyright retention and widespread visibility of the articles published in the journal.
Efficient Review System and Rapid Publication
- An average of 90 days from submission to publication is required for a submitted manuscript to be published in the journal
- The submitted manuscripts are peer-reviewed by the top scholars in the relevant research field, which will indirectly add value to the quality of the manuscript and increase the citations.
- A double-blind peer review process is used to ensure a fair and unbiased review on the submitted manuscript by reserving the identity of both reviewers and authors.
- Low publication fee in the range of USD 300-600 will be charged for different types of the article after acceptance. The authors from low-middle or low-income countries/regions are eligible to apply for the publication fee waiver. Please refer the publication fee below for future details. Rejected articles are not charged any fee.
The authors own the copyright of the published articles. The authors as per rule may recreate duplicates of their articles in any capacity they pick and unreservedly disperse these as reprints or electronically, as long as the first production is completely referred to. For example, the authors’ distributed article can (with the full reference) be posted on their own or institutional homepage, ResearchGate, LinkedIn or other social media, emailed to colleagues, collaborators and partners, printed, documented in an accumulation, conveyed on CD ROM, cited in the press, interpreted or disseminated in some other method to the same number of individuals and as regularly as you wish. The publisher’s articles are Open Access and circulated under the terms of the Creative Commons Attribution License, which allows the utilization, dispersion, and propagation in different discussions, gave the first writers and source are credited.
Bio-Byword Scientific Publishing’s Open Access Policy ensures high visibility and maximum exposure to the work of the authors. Under Open Access Policy, anyone can read the authors’ articles without paying any access or subscription fee. Additionally, the authors’ work can be shared as long as a proper citation and/or acknowledgment is given under the terms of the Creative Commons Attribution License.
The authors’ articles are widely promoted through different media, such as email alerts and, when appropriate, press releases, further increasing the accessibility and spreading of every research work.
Publication In Press
All articles that have been accepted are published electronically online in press, without waiting for a full issue to be published.
There will be no Article Processing Charges (APC) is applicable to all authors who have their manuscript successfully accepted after peer-review in the first two issues. The journal will start to charge APC for the articles accepted for and published in the third issue to cover the cost incurred in processing the manuscripts in order to ensure the contents are freely available and maintain publishing quality. The manuscript processing includes peer review, copy-editing, typesetting, publishing, content depositing and archiving processes. An invoice of APC will be issued after a paper has been accepted, where authors are advised to pay the APC within one week to avoid delay in publication. The APC for different types of articles is as depicted in the table below.
Original Research Article
Letter to the Editor
Color Image (each)
Video File (25 MB each)*
*If the size of the video file exceeds 25 MB, an additional charge of USD 50 will be charged for every 25 MB.
The publisher encourages all authors to publish their manuscripts without concerning the cost of APC to be a barrier especially to authors from the low and lower-middle-income countries/regions. A range of discounts or waivers is offered to authors who are unable to pay the publication processing fees. Authors can write in to apply for a waiver (50-100%) and requests will be considered on a case-by-case basis.
The publisher uses the World Bank Country Classification table to identify low and lower-middle-income countries/regions. While applying for waiver kindly send a cover letter by email to itps.editorial.office.bbwpublisher.com with the following information after acceptance of the manuscript:
- Manuscript ID
- Title of your paper
- Corresponding author name and institution with full address
- Reason for applying for a waiver
- Funding details of the study
- Focus of the manuscript with details on how it will contribute to issues pertaining to the local community or issues in the country of origin of the manuscript
The final decision on the APC discount or waiver is made by the Editorial Office.
Indexing and Archiving
Our ambitious and aspiring Editor-in-Chief and Editorial Board Members aim to get INNOSC Biomaterials and Stem Cells indexed by the world-renowned databases, including:
- Chemical Abstracts Service/SciFinder
- Google Scholar
- J-Gate Portal
- CNKI Scholar
- Suweco CZ
- Ulrich's Periodicals Directory
- Biological Abstracts
- BIOSIS Previews
- Directory of Open Access Journals (DOAJ)
- EBSCOhost Connection
- EBSCOhost Research Databases
- Engineering Village
- HINARI Access to Research in Health Programme
- Index Medicus
- Journal Citation Reports - Science Edition
- Science Citation Index®
- Open Access Journals Integrated Service System Project (GoOA)
- Primo Central Index
- PubMed Central
- Science Citation Index Expanded
- The Summon Service
- WorldCat Discovery Services
- Current Contents®/Life Sciences
- Biochemistry & Biophysics Citation Index®
- ProQuest databases
- Index Chemicus
- Sociedad Iberoamericana de Informacion Cientifica (SIIC) Data Bases